Zeaxanthin Ester Bioproduction Engineering Service

Zeaxanthin Ester (ZE) is a high-value carotenoid derivative used in eye health supplements and cosmetics, providing superior stability and bioavailability compared to free Zeaxanthin. Current sources, such as marigold flowers, yield low extraction amount in plants , requiring extensive farming and harsh chemical processing. Free Zeaxanthin itself exhibits poor stability , being highly susceptible to oxidation and degradation during processing and storage. Biosynthesis in engineered bacteria or yeast offers a sustainable and stable production route.

CD Biosynsis offers a synthetic biology service focused on the high-titer production of Zeaxanthin Ester. Our core strategy involves modification of carotenoid pathway in Escherichia coli . We engineer E. coli by introducing the heterologous gene cluster (CrtE, CrtB, CrtI, CrtY, CrtZ) to synthesize Zeaxanthin. We optimize the flux toward Zeaxanthin by tuning promoter strength and ribosome binding sites. Crucially, this is coupled with the heterologous expression of acyltransferase . We introduce and tune a specific, highly active Acyltransferase (ester synthase) enzyme to efficiently convert the newly synthesized free Zeaxanthin into the highly stable, lipophilic Zeaxanthin Ester form (e.g., dipalmitate, dimyristate). This integrated approach aims to deliver a high-yield, high-purity, and intrinsically stable Zeaxanthin Ester product from a fermentable sugar source.

Pain Points

Developing a competitive Zeaxanthin Ester bioproduction route faces these key technical challenges:

• Low Extraction Amount in Plants: Natural plant sources (like marigold) have low specific yields , requiring vast amounts of biomass, leading to high cost and environmental footprint.
• Poor Stability: Free Zeaxanthin is a highly conjugated polyene molecule, making it extremely vulnerable to degradation by oxygen, light, and heat , complicating its use in finished products.
• Metabolic Bottlenecks: The upstream mevalonate (MVA) or non-mevalonate (MEP) pathways that supply the isopentenyl diphosphate (IPP) precursor are often tightly regulated , limiting the overall flux toward carotenoids.
• Esterification Deficiency: E. coli does not naturally possess the specific Acyltransferase needed to convert the final free Zeaxanthin (a diol) into its highly stable diester form.

A successful solution must overcome precursor supply limitations, ensure efficient assembly of the carotenoid backbone, and perform the final esterification step for stabilization.

Solutions

CD Biosynsis utilizes advanced synthetic biology to engineer E. coli for high-yield Zeaxanthin Ester production:

Modification of Carotenoid Pathway in E. coli

           

We introduce and balance the expression of the Crt gene cluster (E, B, I, Y, Z) and engineer the native MEP pathway to maximize the flux from sugar to free Zeaxanthin.

Heterologous Expression of Acyltransferase

We introduce and optimize the expression of a Zeaxanthin Acyltransferase from a plant or fungal source to efficiently convert the diol into the diester, stabilizing the product in vivo .

Precursor Supply Enhancement

We target key rate-limiting steps in the MEP (Methylerythritol Phosphate) pathway in E. coli to boost the supply of IPP, dramatically increasing overall carotenoid yield.

Intracellular Lipid Storage Optimization

We engineer the host to enhance its ability to form lipid droplets or inclusion bodies , which serve as a sink to accumulate the hydrophobic Zeaxanthin Ester, preventing toxicity and increasing titer.

This systematic approach is focused on maximizing the flux toward the carotenoid pathway and adding the final esterification step for product stabilization.

Advantages

Our Zeaxanthin Ester engineering service is dedicated to pursuing the following production goals:

Significantly Enhanced Stability

Esterification shields the Zeaxanthin backbone, providing superior resistance to oxidation, light, and heat during formulation.

High Specific Titer

Pathway enhancement and storage optimization lead to commercially viable accumulation of the ester product.

Sustainable Production Route

Fermentation is scalable and utilizes renewable sugars , reducing the environmental impact of large-scale agriculture.

Consistent Quality

The controlled environment of the fermenter ensures a reproducible sterol profile and ester composition, unlike variable plant extracts.

Efficient Final Conversion

The overexpressed acyltransferase ensures near-complete conversion of free Zeaxanthin to the desired diester form.

We provide a specialized metabolic engineering platform aimed at optimizing the yield and intrinsic stability of Zeaxanthin Ester compounds.

Process

Our Zeaxanthin Ester strain engineering service follows a rigorous, multi-stage research workflow:

• MEP Pathway Enhancement: Overexpress the key rate-limiting enzymes of the MEP pathway in E. coli to maximize precursor (IPP) supply.
• Carotenoid Cluster Integration: Integrate the heterologous Crt gene cluster (E, B, I, Y, Z) and fine-tune its expression for balanced flux toward Zeaxanthin .
• Esterification Gene Introduction: Introduce and optimize the expression of the target Zeaxanthin Acyltransferase to ensure efficient final product conversion.
• Fatty Acid Precursor Optimization: Modulate the host's fatty acid synthesis pathway to ensure the availability of the desired fatty acid components for esterification (e.g., palmitate or myristate).
• Fermentation Performance Validation: Test the final engineered strain in fed-batch fermentation to assess Zeaxanthin Ester titer, yield, and purity .
• Result Report Output: Compile a detailed Experimental Report including gene modification data, HPLC analysis of the ester profile, and fermentation metrics (yield, titer, and ester ratio) , supporting commercial scale-up.

Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and specific ester structure.

Explore the potential for a high-stability, sustainable Zeaxanthin Ester supply. CD Biosynsis provides customized strain engineering solutions:

• Detailed Carotenoid Profile Analysis Report , demonstrating the successful conversion from free Zeaxanthin to the target Zeaxanthin Ester.
• Consultation on optimized cell lysis and lipid extraction methods for efficient Zeaxanthin Ester recovery from the microbial biomass.
• Experimental reports include complete raw data on carbon yield (g Ester/g sugar) and product stability under standard storage conditions.